Journal
ALZHEIMERS & DEMENTIA
Volume 7, Issue 4, Pages 436-444Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jalz.2010.08.228
Keywords
Alzheimer's disease; Vascular dementia; Intracranial atherosclerosis; Circle of Willis; Brain hypoperfusion
Categories
Funding
- Science Foundation Arizona
- Arizona Department of Health Services (Arizona Alzheimer Disease Research Consortium) [211002]
- National Institute on Aging [R01-AG19795, R01-NS38674]
- Arizona Alzheimer's Disease Core Center [P30 AG-19610]
- Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research
- Baxter
- Lilly
- Wyeth
- Glaxo Smith Kline
- Amerisciences
Ask authors/readers for more resources
Background: A substantial body of evidence collected from epidemiologic, correlative, and experimental studies strongly associates atherosclerotic vascular disease (AVD) with Alzheimer's disease (AD). Depending on the precise interrelationship between AVD and AD, systematic application of interventions used to maintain vascular health and function as a component of standard AD therapy offers the prospect of mitigating the presently inexorable course of dementia. To assess this hypothesis, it is vital to rigorously establish the measures of AVD that are most strongly associated with an AD diagnosis. Methods: A precise neuropathological diagnosis was established for all subjects, using a battery of genetic, clinical, and histological methods. The severity of atherosclerosis in the circle of Willis was quantified by direct digitized measurement of arterial occlusion in postmortem specimens and was compared between AD and nondemented control groups by calculating a corresponding index of occlusion. Results: Atherosclerotic occlusion of the circle of Willis arteries was more extensive in the AD group than in the nondemented control group. Statistically significant differences were also observed between control and AD groups with regard to Braak stage, total plaque score, total neurofibrillary tangle score, total white matter rarefaction score, brain weight, Mini-Mental State Examination scores, and apolipoprotein E allelic frequencies. Conclusions: Our results, combined with a consideration of the multifaceted effects of impaired cerebral circulation, suggest an immediate need for prospective clinical trials to assess the efficacy of AD prevention using antiatherosclerotic agents. (C) 2011 The Alzheimer's Association. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available